📰 4 sources covering this story

Novo outlook hike falls flat as Wegovy pill sales fail to impress

First covered 8 hrs ago · latest take 51 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

Novo outlook hike falls flat as Wegovy pill sales fail to impress
Reuters
Reuters51 mins ago
Novo outlook hike falls flat as Wegovy pill sales fail to impress
Novo outlook hike falls flat as Wegovy pill sales fail to impress  Reuters
Quartz
Quartz4 hrs ago
Novo Nordisk is raising its full-year outlook as its weight loss pill keeps selling
The Danish drugmaker's Wegovy pill has exceeded 5 million prescriptions in the U.S. since launch, driving stronger-than-expected profit
CNBC
CNBC🏁 first to report8 hrs ago
Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.